Journal Title：Cancer Prevention Research

Cancer Prevention Research publishes original studies, reviews, and perspectives in the field of cancer prevention. Its scope includes the molecular and cellular biology of premalignancy and early lesions; genetic and environmental risk factors; risk assessment and reduction; early detection research (cancer screening and diagnosis); and preventive interventions (chemoprevention, immunoprevention, and others) to intercept cancer development at early stages prior to initiation, promotion, or progression. The journal comprises preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.

《癌癥預(yù)防研究》發(fā)表癌癥預(yù)防領(lǐng)域的原創(chuàng)研究、評(píng)論和觀點(diǎn)。其范圍包括癌前病變和早期病變的分子和細(xì)胞生物學(xué)；遺傳和環(huán)境風(fēng)險(xiǎn)因素；風(fēng)險(xiǎn)評(píng)估和降低；早期檢測(cè)研究（癌癥篩查和診斷）；以及預(yù)防干預(yù)措施（化學(xué)預(yù)防、免疫預(yù)防等），以在癌癥發(fā)生、發(fā)展或進(jìn)展之前的早期階段攔截癌癥發(fā)展。該期刊包括臨床前、臨床和轉(zhuǎn)化研究，特別關(guān)注分子發(fā)現(xiàn)，并強(qiáng)調(diào)在基礎(chǔ)科學(xué)和臨床科學(xué)之間建立轉(zhuǎn)化橋梁。

Cancer Prevention Research創(chuàng)刊于2008年，由American Association for Cancer Research Inc.出版商出版，收稿方向涵蓋醫(yī)學(xué) - 腫瘤學(xué)全領(lǐng)域，此刊是中等級(jí)別的SCI期刊，所以過審相對(duì)來講不是特別難，但是該刊專業(yè)認(rèn)可度不錯(cuò)，仍然是一本值得選擇的SCI期刊 。平均審稿速度 偏慢,4-8周 ，影響因子指數(shù)2.9，該期刊近期沒有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。